Serum Institute receives DCGI approval to resume trials of Oxford COVID-19 vaccine
The DCGI has, however, put certain conditions like taking extra care during screening, providing additional information in…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
COVID-19 Updates
RDIF and Dr Reddy’s to partner for trials and supply of 100 mn Sputnik V vaccine doses to India
Deliveries could potentially begin in late 2020 subject to completion of successful trials and registration of the vaccine by…
Why COVID-19 presents a golden opportunity to Indian pharma firms
Juilee Dandekar, Sector Expert - Healthcare, Business Research & Advisory, Aranca informs that with India Pharma Inc's…
CSIR and Aurobindo Pharma to collaborate for COVID-19 vaccine development
DBT is also supporting Aurobindo Pharma’s COVID-19 vaccine development through its wholly-owned US subsidiary Auro Vaccines, under…
Novavax expands deal with Serum Institute, aims for two billion COVID-19 vaccine doses
Serum Institute will also manufacture the antigen component of the vaccine, dubbed NVX‑CoV2373
Baricitinib in combination with remdesivir reduces recovery time in hospitalised COVID-19 patients:…
Data from the Adaptive COVID-19 Treatment Trial (ACTT-2) revealed an approximately one-day reduction in median recovery time for…
UK researchers to test inhaled versions of Oxford and Imperial COVID-19 vaccine candidates
Delivering the vaccine to the respiratory tract may be a good approach to inducing immune responses in the best place to enable a…
Kiadis to collaborate with Abigail Wexner Research Institute for clinical trials of COVID-19 therapy
The US FDA approved AWRI’s investigational new drug application (IND) for a study in an adult population with off-the-shelf…
Discord between IMA and MSN Labs over promotion of COVID-19 drug, Favilow
The doctors’ body claims misuse of its identity in the drug’s promotion while the pharma firm asserts that it has email expressing…
Saptagir Labs signs manufacturing deal with Jubilant Generics for remdesivir
The drug will be produced at its sterile drug product manufacturing plant in Hyderabad which is WHO GMP certified
Will take first dosage of COVID-19 vaccine if people have trust deficit: Dr Harsh Vardhan
The Government is considering emergency authorisation of COVID-19 vaccination especially in the case of senior citizens and people…
Applied Biology and Corpometria Institute to launch anti-androgen clinical study for COVID-19…
Discovery potentially links SARS-CoV-2 infectivity to androgens, the same hormones implicated in male pattern baldness and…
Pfizer and BioNTech submit proposal to US FDA to expand COVID-19 vaccine trial
The companies expect that a conclusive readout on efficacy is likely by the end of October
Clinical trials of AstraZeneca-Oxford COVID-19 vaccine candidate resumes in UK
This is following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so
We are prepared to take on significant volumes from pharma partners working on COVID-19 vaccines
Megan Williamson, Head of Sales, Americas Datwyler elaborates how Datwyler is gearing up to meet the requirements of pharma…
COVAXIN demonstrates protective efficacy in animal studies: Bharat Biotech
A two-dose vaccination regimen, administered in 20 rhesus macques, showed increasing SARS-CoV-2 specific IgG and neutralizing…
NII’s COVID-19 vaccine candidate exhibits positive results in immunogenicity study on mice
The Director of the Institute said that more tests need to be done on mice on a larger scale now and it is expected to start next…
Patient activist groups express relief over pause of Covishield trials in India
They call for more timely responses and accountability on part of both regulators and companies to ensure patient safety
PNB Vesper gets DCGI nod to test proprietary drug PNB 001 in COVID-19 patients
A study will be conducted on 40 moderately-ill COVID-19 patients at BMJ Medical College, Pune who are on oxygen support
Pfizer and BioNTech to potentially supply EU with 200 mn doses of COVID-19 vaccine candidate
The proposed agreement also has an option to purchase additional 100 million doses, with deliveries starting by the end of 2020,…